1Ridker PM,Danielson E,Fonseca FA,et al; JUPITER Study Group.Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein.N Engl J Med,2008,359:2195-2207.
2de Lorgeril M,Salen P,Abramson J,et al.Cholesterol lowering,cardiovascular diseases,and the rosuvastatin-JUPITER controversy: a critical reappraisal.Arch Intern Meg,2010,170:1032-1036.
3Kaul S,Morrissey RP,Diamon GA.By Jove! What is a clinician to make of JUPITER? Arch Intern Med,2010,170:1073-1077.
4Ray KK,Seshasai SR,Erqou S,et al.Statins and all-cause mortality in high-risk primary prevention: a meta-analysis of 11randomized controlled trials involving 65,229 participants.Arch Intern Meg,2010,170:1024-1031.
5Green LA.Cholesterol-lowering therapy for primary prevention:still much we don't know.Arch Intern Meg,2010,170: 1007-1008.
